"10.1371_journal.pone.0056024","plos one","2013-02-13T00:00:00Z","Alex Gutteridge; J Michael Rukstalis; Daniel Ziemek; Mark Tié; Lin Ji; Rebeca Ramos-Zayas; Nancy A Nardone; Lisa D Norquay; Martin B Brenner; Kim Tang; John D McNeish; Rebecca K Rowntree","Pfizer Regenerative Medicine, Cambridge, Massachusetts, United States of America; Pfizer Regenerative Medicine, Cambridge, United Kingdom; Pfizer Computational Sciences Center of Emphasis, Cambridge, Massachusetts, United States of America; Pfizer Cardiovascular and Metabolic Diseases, Cambridge, Massachusetts, United States of America","Conceived and designed the experiments: RKR AG DZ JMR KT JDM. Performed the experiments: AG JMR DZ MT LJ RR-Z NAN LDN MBB RKR. Analyzed the data: AG JMR DZ KT RKR. Wrote the paper: AG JMR DZ RKR.","The authors have the following conflicts: authors Alex Gutteridge, J. Michael Rukstalis, Daniel Ziemek, Mark Tié, Lin Ji, Rebeca Ramos-Zayas, Nancy A. Nardone, Lisa D. Norquay, Martin B. Brenner, Kim Tang, John D. McNeish and Rebecca K. Rowntree are affiliated to Pfizer Inc the funder of this study. There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.",NA,NA,NA,"2013","02","Alex Gutteridge","AG",12,TRUE,6,10,5,4,TRUE,TRUE,FALSE,0,NA,FALSE
